{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:08:09Z","timestamp":1793660889298,"version":"4.5.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024506","name":"Faculty of Medical Sciences, Tarbiat Modares University","doi-asserted-by":"publisher","award":["MED15712317"],"award-info":[{"award-number":["MED15712317"]}],"id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.micpath.2025.107567","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:42:42Z","timestamp":1744303362000},"page":"107567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Designing a multi-epitope vaccine using Toxoplasma ROP5, ROP7, and SAG1 epitopes and immunogenicity evaluation against acute and chronic toxoplasmosis in BABL\/c mice"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2064-5968","authenticated-orcid":false,"given":"Zeinab","family":"Moghadamizad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5591-5513","authenticated-orcid":false,"given":"Abdolhossein","family":"Dalimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-4772","authenticated-orcid":false,"given":"Majid","family":"Pirestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0891-8214","authenticated-orcid":false,"given":"Fatemeh","family":"Ghafarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.micpath.2025.107567_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/pathogens10111351","article-title":"Comprehensive overview of Toxoplasma gondii-induced and associated diseases","volume":"10","author":"Daher","year":"2021","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib2","first-page":"1","article-title":"Latent toxoplasmosis and human","volume":"7","author":"Dalimi","year":"2012","journal-title":"Iran. J. Parasitol."},{"key":"10.1016\/j.micpath.2025.107567_bib3","series-title":"Toxoplasma Gondii","first-page":"1","article-title":"The history and life cycle of Toxoplasma gondii","author":"Dubey","year":"2014"},{"issue":"8","key":"10.1016\/j.micpath.2025.107567_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.micpath.2025.107567_bib5","first-page":"389","article-title":"Toxoplasma gondii infection in immunocompromised patients: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Microbiol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107567_bib6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1017\/S0031182021001013","article-title":"Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections","volume":"148","author":"Dubey","year":"2021","journal-title":"Parasitology"},{"key":"10.1016\/j.micpath.2025.107567_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2471\/BLT.12.111732","article-title":"The global burden of congenital toxoplasmosis: a systematic review","volume":"91","author":"Torgerson","year":"2013","journal-title":"Bull. World Health Organ."},{"issue":"11","key":"10.1016\/j.micpath.2025.107567_bib8","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expet Rev. Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11845-022-02998-9","article-title":"Toxoplasma gondii vaccine candidates: a concise review","volume":"192","author":"Mamaghani","year":"2023","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.micpath.2025.107567_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","article-title":"A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization","volume":"126","author":"Rezaei","year":"2019","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/14760584.2023.2157818","article-title":"Insight into the current Toxoplasma gondii DNA vaccine: a review article","volume":"22","author":"Zhang","year":"2023","journal-title":"Expet Rev. Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41541-022-00563-0","article-title":"Toxoplasmosis vaccines: what we have and where to go?","volume":"7","author":"Zhang","year":"2022","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micpath.2025.107567_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101414","article-title":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: a systematic review","volume":"69","author":"Pagheh","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107567_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cimid.2018.09.005","article-title":"Vaccination against Toxoplasma gondii using rhoptry antigens: a systematic review","volume":"59","author":"Faridnia","year":"2018","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"20","key":"10.1016\/j.micpath.2025.107567_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011262","article-title":"Toxoplasma gondii ROP5 enhances type I IFN responses by promoting ubiquitination of STING","volume":"25","author":"Jin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib16","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41420-023-01742-1","article-title":"Toxoplasma rhoptry proteins that affect encephalitis outcome","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.micpath.2025.107567_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116567","article-title":"Rhoptry proteins affect the placental barrier in the context of Toxoplasma gondii infection: signaling pathways and functions","volume":"280","author":"Wang","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"10","key":"10.1016\/j.micpath.2025.107567_bib18","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/cells11101630","article-title":"Toxoplasma gondii rhoptry protein 7 (ROP7) interacts with NLRP3 and promotes inflammasome hyperactivation in THP-1-derived macrophages","volume":"11","author":"Zhu","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.micpath.2025.107567_bib19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.drudis.2020.03.006","article-title":"Epitope-based vaccine design: a comprehensive overview of bioinformatics approaches","volume":"25","author":"Parvizpour","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.micpath.2025.107567_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa062","article-title":"NCBI Taxonomy: a comprehensive update on curation, resources and tools","volume":"2020","author":"Schoch","year":"2020","journal-title":"Database"},{"issue":"4","key":"10.1016\/j.micpath.2025.107567_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B\u2010cell epitopes using string kernels","volume":"21","author":"EL\u2010Manzalawy","year":"2008","journal-title":"J. Mol. Recogn.: An Interdisciplinary J."},{"issue":"D1","key":"10.1016\/j.micpath.2025.107567_bib22","doi-asserted-by":"crossref","first-page":"D339","DOI":"10.1093\/nar\/gky1006","article-title":"The immune epitope database (IEDB): 2018 update","volume":"47","author":"Vita","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2025.107567_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104925","article-title":"Multi-epitope vaccine expressed in Leishmania tarentolae confers protective immunity to Toxoplasma gondii in BALB\/c mice","volume":"155","author":"Majidiani","year":"2021","journal-title":"Microb. Pathog."},{"issue":"11","key":"10.1016\/j.micpath.2025.107567_bib24","first-page":"10","article-title":"Immunogenicity prediction by VaxiJen: a ten year overview","volume":"10","author":"Zaharieva","year":"2017","journal-title":"J. Proteonomics Bioinf."},{"issue":"23","key":"10.1016\/j.micpath.2025.107567_bib25","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics"},{"issue":"suppl_2","key":"10.1016\/j.micpath.2025.107567_bib26","doi-asserted-by":"crossref","first-page":"W202","DOI":"10.1093\/nar\/gkl343","article-title":"AlgPred: prediction of allergenic proteins and mapping of IgE epitopes","volume":"34","author":"Saha","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"17","key":"10.1016\/j.micpath.2025.107567_bib27","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1093\/bioinformatics\/btp386","article-title":"SOLpro: accurate sequence-based prediction of protein solubility","volume":"25","author":"Magnan","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2025.107567_bib28","series-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.micpath.2025.107567_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/A:1006960004440","article-title":"NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility","volume":"15","author":"Hansen","year":"1998","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.micpath.2025.107567_bib30","first-page":"310","article-title":"Prediction of glycosylation across the human proteome and the correlation to protein function","author":"Gupta","year":"2002","journal-title":"Biocomputing"},{"issue":"7","key":"10.1016\/j.micpath.2025.107567_bib31","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/bioinformatics\/bti130","article-title":"NetAcet: prediction of N-terminal acetylation sites","volume":"21","author":"Kiemer","year":"2005","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.micpath.2025.107567_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1006\/jmbi.1999.3310","article-title":"Sequence and structure-based prediction of eukaryotic protein phosphorylation sites","volume":"294","author":"Blom","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2025.107567_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0076-6879(96)66034-0","article-title":"[32] GOR method for predicting protein secondary structure from amino acid sequence","volume":"266","author":"Garnier","year":"1996","journal-title":"Methods Enzymol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER Suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat. Methods"},{"issue":"W1","key":"10.1016\/j.micpath.2025.107567_bib35","doi-asserted-by":"crossref","first-page":"W384","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.micpath.2025.107567_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Crystallogr."},{"issue":"23","key":"10.1016\/j.micpath.2025.107567_bib37","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.micpath.2025.107567_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.micpath.2025.107567_bib39","series-title":"Proceedings of the Sixteenth International Symposium on Mathematical Theory of Networks and Systems (MTNS2004)","article-title":"C-immsim: playing with the immune response","year":"2004"},{"issue":"suppl_2","key":"10.1016\/j.micpath.2025.107567_bib40","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2025.107567_bib41","series-title":"Short Protocols in Protein Science: a Compendium of Methods from Current Protocols in Protein Science","author":"Coligan","year":"2003"},{"key":"10.1016\/j.micpath.2025.107567_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3103\/S0891416819010099","article-title":"Evaluation of anti-Toxoplasma gondii immune responses in BALB\/c mice induced by DNA vaccines encoding surface antigen 1 (SAG1) and 3 (SAG3)","volume":"34","author":"Sobati","year":"2019","journal-title":"Mol. Genet. Microbiol. Virol."},{"issue":"11","key":"10.1016\/j.micpath.2025.107567_bib43","first-page":"4121","article-title":"Real-time PCR for quantitative detection of Toxoplasma gondii","volume":"38","author":"Lin","year":"2000"},{"key":"10.1016\/j.micpath.2025.107567_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-494","article-title":"DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB\/c mice","volume":"13","author":"Meng","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.micpath.2025.107567_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biologicals.2020.10.002","article-title":"Next-generation vaccines and the impacts of state-of-the-art in-silico technologies","volume":"69","author":"Salemi","year":"2020","journal-title":"Biologicals"},{"key":"10.1016\/j.micpath.2025.107567_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/vaccines12010071","article-title":"DNA Vaccines: their formulations, engineering and delivery","volume":"12","author":"Kozak","year":"2024","journal-title":"Vaccines."},{"issue":"12","key":"10.1016\/j.micpath.2025.107567_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008097","article-title":"Human immunity to Toxoplasma gondii","volume":"15","author":"Fisch","year":"2019","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib49","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12879-024-09807-x","article-title":"TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches","volume":"24","author":"Majidiani","year":"2024","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46408-1","article-title":"Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis","volume":"13","author":"Basmenj","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib51","first-page":"100","article-title":"Preliminary in silico analysis of adenylate kinase 1 (ADK1) of echinococcus granulosus as a candidate for vaccination against cystic echinococcosis","volume":"19","author":"Hashemi","year":"2025","journal-title":"Recent Adv. Inflamm. Allergy Drug Dis."},{"key":"10.1016\/j.micpath.2025.107567_bib52","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.micpath.2014.03.006","article-title":"TLR4 in Toxoplasmosis; friends or foe?","volume":"69","author":"Zare-Bidaki","year":"2014","journal-title":"Microb. Pathog."},{"issue":"3","key":"10.1016\/j.micpath.2025.107567_bib53","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/intimm\/dxy004","article-title":"Host immune responses to Toxoplasma gondii","volume":"30","author":"Sasai","year":"2018","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.micpath.2025.107567_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14760584.8.2.215","article-title":"Vaccination concepts against Toxoplasma gondii","volume":"8","author":"Garcia","year":"2009","journal-title":"Expet Rev. Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib55","article-title":"Does Toxoplasma gondii infection affect the levels of IgE and cytokines (IL\u20105, IL\u20106, IL\u201010, IL\u201012, and TNF\u2010alpha)?","volume":"2009","author":"Matowicka-Karna","year":"2009","journal-title":"J. Immunol. Res."},{"issue":"9","key":"10.1016\/j.micpath.2025.107567_bib56","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.4049\/jimmunol.180.9.5935","article-title":"IL-12 signaling drives CD8+ T cell IFN-\u03b3 production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection","volume":"180","author":"Wilson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.107567_bib57","series-title":"Seminars in Immunopathology","article-title":"Immune response and immunopathology during toxoplasmosis","year":"2012"},{"issue":"52","key":"10.1016\/j.micpath.2025.107567_bib58","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1016\/j.vaccine.2013.10.034","article-title":"DNA immunization with eukaryotic initiation factor-2\u03b1 of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice","volume":"31","author":"Chen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107567_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-6-63","article-title":"Compound DNA vaccine encoding SAG1\/SAG3 with A 2\/B subunit of cholera toxin as a genetic adjuvant protects BALB\/c mice against Toxoplasma gondii","volume":"6","author":"Cong","year":"2013","journal-title":"Parasites Vectors"},{"issue":"4","key":"10.1016\/j.micpath.2025.107567_bib60","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.vaccine.2010.11.012","article-title":"Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis","volume":"29","author":"Khosroshahi","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.107567_bib61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biologicals.2019.10.002","article-title":"Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB\/c mice","volume":"62","author":"Maraghi","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.micpath.2025.107567_bib62","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/IDR.S209270","article-title":"Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of Toxoplasma gondii in BALB\/c mice","author":"Mavi","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.micpath.2025.107567_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-5-273","article-title":"Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB\/c mice","volume":"5","author":"Meng","year":"2012","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.micpath.2025.107567_bib64","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00436-012-3047-y","article-title":"Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice","volume":"111","author":"Wu","year":"2012","journal-title":"Parasitol. Res."},{"issue":"10","key":"10.1016\/j.micpath.2025.107567_bib65","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2012.01.004","article-title":"Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rvsc.2010.01.007","article-title":"The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18","volume":"89","author":"Liu","year":"2010","journal-title":"Res. Vet. Sci."},{"issue":"4","key":"10.1016\/j.micpath.2025.107567_bib67","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/pim.12306","article-title":"Evaluation of immune responses induced by rhoptry protein 5 and rhoptry protein 7 DNA vaccines against Toxoplasma gondii","volume":"38","author":"Wang","year":"2016","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.micpath.2025.107567_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104435","article-title":"Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB\/c mice","volume":"147","author":"Foroutan","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.micpath.2025.107567_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101413","article-title":"Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice","volume":"69","author":"Foroutan","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107567_bib70","first-page":"2","article-title":"Evaluation of immune responses induced by GRA7 and ROP2 genes by DNA vaccine cocktails against acute toxoplasmosis in BALB\/c mice","volume":"10","author":"Vazini","year":"2018","journal-title":"Avicenna J. Med. Biotechnol. (AJMB)"},{"key":"10.1016\/j.micpath.2025.107567_bib71","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00436-007-0465-3","article-title":"Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB\/c mice","volume":"101","author":"Zhang","year":"2007","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.micpath.2025.107567_bib72","doi-asserted-by":"crossref","DOI":"10.1051\/parasite\/2020021","article-title":"Adjuvantic cytokine IL-33 improves the protective immunity of cocktailed DNA vaccine of ROP5 and ROP18 against Toxoplasma gondii infection in mice","volume":"27","author":"Zhu","year":"2020","journal-title":"Parasite"},{"issue":"41","key":"10.1016\/j.micpath.2025.107567_bib73","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","article-title":"The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice","volume":"31","author":"Zheng","year":"2013","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.micpath.2025.107567_bib74","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1007\/s00436-015-4701-y","article-title":"Towards vaccine against toxoplasmosis: evaluation of the immunogenic and protective activity of recombinant ROP5 and ROP18 Toxoplasma gondii proteins","volume":"114","author":"Grzybowski","year":"2015","journal-title":"Parasitol. Res."},{"issue":"4","key":"10.1016\/j.micpath.2025.107567_bib75","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14760584.2015.1011133","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice","volume":"14","author":"Chen","year":"2015","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2025.107567_bib76","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VDT.S57474","article-title":"Current progress toward vaccines against Toxoplasma gondii","author":"Garcia","year":"2014","journal-title":"Vaccine Dev. Ther."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102500292X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102500292X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T21:08:17Z","timestamp":1769202497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102500292X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":76,"alternative-id":["S088240102500292X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107567","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing a multi-epitope vaccine using Toxoplasma ROP5, ROP7, and SAG1 epitopes and immunogenicity evaluation against acute and chronic toxoplasmosis in BABL\/c mice","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107567"}}